Nanjing Well Pharmaceutical Group Co.,Ltd.
603351.SS
Price:
$26.02
Market Cap:
$3.52B
Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical auxiliary materials in China. Its pharmaceutical materials include excipients for injectables and non-injectables. The company also provides synthetic base oils, such as hydraulic fluids, lubricity additives for metals, metal quenching, base fluids and lubricity additives, synthetic base for compress lubricants, synthetic base oil for gear, base oil of chain lubricants, base stock of engine oil, base stock of heat transfer oil, and base oil of grease; and other products, including painting and coating, textile chemicals, field chemicals, and low foam metal cleaners. It a...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2019-02-11
Stock Exchange
SHH
Ticker
603351.SS
PE Ratio
[23.87]
ROE
[8.53%]
Current Ratio
[1.29]
Dividend Yield
[1.54%]
Enterprise Value
[3.77B]
Dividend History
The ROE as of December 2025 (TTM) for Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) is 8.53%
According to Nanjing Well Pharmaceutical Group Co.,Ltd.’s latest financial reports and current stock price. The company's current ROE is 8.53%. This represents a change of 300.29% compared to the average of 2.13% of the last 4 quarters.
Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) Historical ROE (quarterly & annually)
How has 603351.SS ROE performed in the past?
The mean historical ROE of Nanjing Well Pharmaceutical Group Co.,Ltd. over the last ten years is 12.31%. The current 8.53% ROE has changed -30.69% with respect to the historical average. Over the past ten years (40 quarters), 603351.SS's ROE was at its highest in in the March 2017 quarter at 6.22%. The ROE was at its lowest in in the December 2022 quarter at 1.11%.
Average
12.31%
Median
9.46%
Minimum
6.42%
Maximum
20.63%
Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) ROE by Quarter and Year
Discovering the peaks and valleys of Nanjing Well Pharmaceutical Group Co.,Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 21.49%
Maximum Annual ROE = 20.63%
Minimum Annual Increase = -43.27%
Minimum Annual ROE = 6.42%
| Year | ROE | Change |
|---|---|---|
| 2024 | 8.60% | 21.49% |
| 2023 | 7.08% | 10.31% |
| 2022 | 6.42% | -12.44% |
| 2021 | 7.33% | -5.14% |
| 2020 | 7.73% | -25.12% |
| 2019 | 10.32% | -43.27% |
| 2018 | 18.19% | -9.78% |
| 2017 | 20.16% | 21.41% |
| 2016 | 16.61% | -19.48% |
| 2015 | 20.63% | 10.43% |
Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) Average ROE
How has 603351.SS ROE performed in the past?
The current ROE of Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.37%
5-year avg
7.43%
10-year avg
12.31%
Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) ROE vs. Peers
How is 603351.SS’s ROE compared to its peers?
Nanjing Well Pharmaceutical Group Co.,Ltd.’s ROE is less than Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (17.53%), less than PKU HealthCare Corp.,Ltd. (9.14%), less than Tibet AIM Pharm. Inc. (11.20%), greater than Zhongzhu Healthcare Holding Co.,Ltd (-32.45%), less than Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (13.84%), less than Henan Taloph Pharmaceutical Stock Co.,Ltd (2.96%), less than Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (7.25%), less than Shandong Wohua Pharmaceutical Co., Ltd. (10.87%), less than Jiangxi Synergy Pharmaceutical Co., Ltd. (4.04%), greater than Huaren Pharmaceutical Co., Ltd. (-106.15%),
| Company | ROE | Market cap |
|---|---|---|
| 17.53% | $3.51B | |
| 9.14% | $3.89B | |
| 11.20% | $3.29B | |
| -32.45% | $5.13B | |
| 13.84% | $3.15B | |
| 2.96% | $3.90B | |
| 7.25% | $3.35B | |
| 10.87% | $3.56B | |
| 4.04% | $3.28B | |
| -106.15% | $3.91B |
Build a custom stock screener for Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanjing Well Pharmaceutical Group Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Nanjing Well Pharmaceutical Group Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Nanjing Well Pharmaceutical Group Co.,Ltd.'s ROE?
How is the ROE calculated for Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)?
What is the highest ROE for Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)?
What is the 3-year average ROE for Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)?
What is the 5-year average ROE for Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)?
How does the current ROE for Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) compare to its historical average?